Navigation Links
Senetek PLC Reports Second Quarter 2009 Financial Results
Date:8/14/2009

er Service, who brings nearly 25 years of pharmaceutical and related customer service and sales experience to Senetek. Ryals spent 12 years working with GlaxoSmithKline's dermatology portfolio.

In early June, Senetek announced a six year extension of existing rights under its agreement with the Czech Republic Institute of Experimental Botany to receive exclusive global licenses, for all applications, to any cytokinin developed, in-licensed or otherwise acquired by the Institute and the right to co-exploit with the Institute any cytokinins that Senetek does not elect to in-license. Senetek also has a right of first refusal before the Institute can license any of its non-cytokinin compounds to any third party for cosmeceutical or anti-aging dermatological applications. In addition, a new group of compounds, "supercytokin plus", has been added to the agreement. The Institute will also perform enhanced research activities in the areas of pre-selective assay, development of analytical methods, stability testing, large scale synthesis and molecular mechanism of action. Visit the Institute's website at www.ueb.cas.cz.

Clinical studies demonstrate that PyratineXR is an anti-aging compound that can help "Beat Red" with 67% less redness, 84% smoother skin and 41% more moisture. Physician-strength PyratineXR is clinically proven to relieve redness (erythema), soothe irritation, increase moisture and repair damaged skin quickly and effectively. Clinical studies have demonstrated that PyratineXR significantly reduces the appearance of lesions (papules and pustules), spider veins and dark spots. In addition, PyratineXR improves skin texture in just days while improving dry, flaky skin by restoring the skin's barrier function and increasing moisture retention. PyratineXR offers an option for inflammatory skin conditions such as rosacea, acn
'/>"/>

SOURCE Senetek PLC
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany
2. Senetek PLC Reports First Quarter 2009 Financial Results
3. Senetek PLC Reports 2008 Financial Results
4. Dynamics Group AG Publishes Research Report on Senetek
5. Senetek Announces Termination of Invicorp(R) License Agreement With Ardana Bioscience Limited
6. Senetek Announces Plan for Promotion, Sales and Distribution of Pyratine-6(TM)
7. Senetek PLC Resolves Dispute With Marketer of Pyratine-6(TM) on Most Favorable Terms
8. Senetek PLC Announces Key Personnel Appointments
9. Senetek PLC Reports 2007 Financial Results
10. Senetek PLC Announces North American Partner for Invicorp(R) Secures Financing for Advancement of Marketing and Development Efforts
11. Senetek PLC Announces Launch of New Website
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... online in The Gerontologist reports ... associated with a decrease in anxiety about death and ... over their lives. In particular, listening to gospel music ... and an increase in sense of control. , These ... men, and individuals of both low- and high-socioeconomic status. ...
(Date:4/18/2014)... What,s one of your worst memories? How did it ... felt during a negative personal experience, such as how ... lead to emotional distress, especially when you can,t stop ... creep up, thinking about the context of the memories, ... and effective way to alleviate the negative effects of ...
(Date:4/18/2014)... (April 18, 2014) ― A new study in the ... patterns in health-related Google searches reveals a recurring pattern ... , Investigators from San Diego State University, ... Monday Campaigns, analyzed "healthy" Google searches (searches that included ... diet") originating in the U.S. from 2005 to 2012. ...
(Date:4/17/2014)... inflammation in benign prostate tissue was associated with ... was found even in those with low prostate-specific ... in Cancer Epidemiology, Biomarkers & Prevention , ... Research. , An analysis of prostate tissue biopsies ... of the Prostate Cancer Prevention Trial (PCPT) found ...
(Date:4/17/2014)... relief targets that could be used to provide ... College London made the discovery when researching how ... the body. , Dr Marzia Malcangio said: "We ... generation and our findings could help chemotherapy patients ... potential side effect of some chemotherapy drugs (such ...
Breaking Medicine News(10 mins):Health News:Religious music brings benefit to seniors' mental health 2Health News:New study suggests a better way to deal with bad memories 2Health News:New study suggests a better way to deal with bad memories 3Health News:New research shows people are thinking about their health early in the week 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 2Health News:Chronic inflammation may be linked to aggressive prostate cancer 3Health News:New pain relief targets discovered 2
... 11 General Nutrition Centers, Inc.,("GNC" the "Company" ... supplements, today reported its financial results for the ... is an indirect wholly owned subsidiary of GNC ... Management LLC ("Ares") and,Ontario Teachers, Pension Plan Board ...
... Cards Before Holidays, WASHINGTON, Nov. 11 The American ... holiday cards to service men,and women in the United States ... 10, the public is invited to send holiday,cards with their ... box.,The Red Cross and Pitney Bowes will then screen cards ...
... 11 Nordic Naturals announces,their new Spa Collection, ... formulas: Omega Radiance(TM) and Omega Therapi(TM). Based on,Norwegian ... the hair and skin with omega-3 and omega-6 ... optimal results. Omega-3s and omega-6s,are considered essential because ...
... One of the most prestigious awards in nursing, The Magnet Prize, was ... the National Magnet Conference recently in Salt Lake City, UT. This ... ... (Vocus) November 11, 2008 -- One of the most prestigious awards in ...
... Utero Injuries, is now available free from Clifford Law Offices web site ... on their website in an effort to educate the public about legal ... , ... Chicago, IL (PRWEB) November 11, 2008 -- A new article, ...
... 2008 Frost &,Sullivan European Health Ingredient of the ... of its pioneering efforts in developing the novel,ingredient ... than cure, current medical treatments for osteoarthritis only,address ... Frost & Sullivan,Research Analyst Kaushik Ghosh. "FORTIGEL(R) represents ...
Cached Medicine News:Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 2Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 3Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 4Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 5Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 6Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 7Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 8Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 9Health News:General Nutrition Centers, Inc. Reports Third Quarter 2008 Financial Results 10Health News:'Holiday Mail for Heroes' to Deliver One Million Cards to Service Members and Families 2Health News:'Holiday Mail for Heroes' to Deliver One Million Cards to Service Members and Families 3Health News:Nordic Naturals Offers Radiant Beauty From the Inside Out With New Spa Collection of Essential Fatty Acid Supplements 2Health News:Abington Memorial One of Just Six Hospitals in the U.S. to Win Magnet Prize 2Health News:Abington Memorial One of Just Six Hospitals in the U.S. to Win Magnet Prize 3Health News:Free Article Now Available: 'Rights Expanding for Plaintiffs with In Utero Injuries' 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 2Health News:Frost & Sullivan Honours GELITA for Developing European Health Ingredient of the Year 3
(Date:1/15/2014)... 15, 2014 MultiCell Technologies, Inc. (OTC Bulletin Board: ... patent application concerning composition of matter, biological targets, mechanism ... cell death.  This patent application describes ... RNA molecules (VSRNAs) which interfere with the basic homeostatic ...
(Date:1/15/2014)... GENEVA, Ill. , Jan. 15, 2014 The ... a Medical Fitness Center by the Medical Fitness Association, ... centers to achieve their full potential. The Cadence Fitness ... in the western suburbs and second in the Chicagoland ...
(Date:1/15/2014)... NEW YORK , Jan. 15, 2014 ... research report is available in its catalogue: ... & Forecast – Worldwide Analysis ... Pump Market Analysis ...
Breaking Medicine Technology:MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 2MultiCell Technologies Files Patent Application Covering New Class of RNA Therapeutics 3Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3Insulin Pump Market & Forecast - Worldwide Analysis 2Insulin Pump Market & Forecast - Worldwide Analysis 3Insulin Pump Market & Forecast - Worldwide Analysis 4Insulin Pump Market & Forecast - Worldwide Analysis 5Insulin Pump Market & Forecast - Worldwide Analysis 6Insulin Pump Market & Forecast - Worldwide Analysis 7Insulin Pump Market & Forecast - Worldwide Analysis 8Insulin Pump Market & Forecast - Worldwide Analysis 9Insulin Pump Market & Forecast - Worldwide Analysis 10Insulin Pump Market & Forecast - Worldwide Analysis 11Insulin Pump Market & Forecast - Worldwide Analysis 12Insulin Pump Market & Forecast - Worldwide Analysis 13Insulin Pump Market & Forecast - Worldwide Analysis 14Insulin Pump Market & Forecast - Worldwide Analysis 15Insulin Pump Market & Forecast - Worldwide Analysis 16Insulin Pump Market & Forecast - Worldwide Analysis 17
... Feb. 28, 2012  Insmed Incorporated (Nasdaq CM: INSM), a biopharmaceutical ... 13th, 2012, at 8:30 AM ET, to discuss its ...  Insmed intends to issue its quarterly and year-end financial ... 13th. To participate in the live ...
... 2012   OncoSec Medical Incorporated (OTCBB: ONCS), which ... therapies to treat solid tumor cancers, today announced that ... the University of California San Francisco and the first ... trial evaluating OncoSec,s OMS ElectroImmunotherapy for the ...
Cached Medicine Technology:Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call 2Insmed to Host Fourth Quarter and 2011 Year-End Earnings Conference Call 3OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 2OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 3OncoSec Doses First Patient in Phase II Clinical Trial for Metastatic Melanoma 4
Inquire...
The Diagnostic Automation, Inc. (DAI) Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) is intended for the in vitro determination of IgM antibody to Measles in human serum....
... For over 30 years, Digisonics has ... workstations with the first review station, ... management, and the best multi-modality reporting., ... performance image review workstations, professional reporting ...
... glucocorticoid produced by the adrenal cortex in ... secreted with a circadian periodicity, and peaks ... Cortisol is often elevated in major depressive ... and in the visceral fat of obese ...
Medicine Products: